GLP-1 Class
Tirzepatide
COA VERIFIEDPOPULAR

Tirzepatide

C₂₂₅H₃₄₈N₄₈O₆₈

GLP-1 Class
HPLC PURITY98.6%

Dual GIP/GLP-1 receptor agonist studied for glucose metabolism and body composition research.

Molecular Weight
4813.45 g/mol
Appearance
White lyophilized powder
Storage
Store at -20°C. Protect from light.

Select Size

Quantity

1
$99.99

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This dual-acting mechanism represents a significant advancement in metabolic research. Clinical studies have demonstrated significant effects on glycemic control and body weight reduction. The compound has been extensively studied in randomized controlled trials, making it one of the most well-characterized metabolic peptides in current research.

Related Compounds

Semaglutide
COA VERIFIEDPOPULARNEW

GLP-1 Class

Semaglutide

C₁₈₇H₂₉₁N₄₅O₅₉

GLP-1 receptor agonist extensively studied for metabolic research and glucose homeostasis.

HPLC PURITY98.5%
From $79.99
Retatrutide
COA VERIFIEDNEW

GLP-1 Class

Retatrutide

C₂₂₇H₃₄₈N₄₈O₆₈S

Novel triple agonist (GIP/GLP-1/glucagon) peptide under investigation for metabolic research.

HPLC PURITY98.3%
From $89.99

Research Use Only — Legal Disclaimer

All products sold by Halo Peptides are strictly intended for in-vitro research, laboratory use, and scientific investigation only. They are not intended for human consumption, veterinary use, diagnostic purposes, or any therapeutic application. By browsing this website and purchasing any product, you acknowledge and agree that you are a qualified researcher and will use all compounds in compliance with applicable local, national, and international laws and regulations.